CD8A and melanoma: In the melanoma case, MarsGT identified two CD8+ Mucosal-associated invariant T (MAIT)-like rare subpopulations and revealed that high IFN-I response hinders these MAIT-like cell responses by upregulating IL10 and inducing IL15 and IL12 from DC in patients who responded to immune checkpoint blockade.